Question

A female adolescent seeks evaluation at the outpatient endocrinology clinic due to distressing changes in her physical appearance. Over the preceding year, she has developed coarse, dark hair on her chin and upper lip, along with persistent nodulocystic acne that has not responded to topical therapies. She achieved menarche at $12$ years of age, but her menstrual cycles have become increasingly erratic, currently occurring at intervals of $3$ to $5$ months. Blood pressure is $112/72 \text{ mmHg}$ and body mass index is $23 \text{ kg/m}^2$. Physical examination reveals a Ferriman-Gallwey score of $11$, with normal breast and female external genital development. There is no clitoromegaly.

Early morning serum analyses yield the following results:
Total testosterone: $92 \text{ ng/dL}$ (Normal: $15-70 \text{ ng/dL}$)
Dehydroepiandrosterone sulfate (DHEA-S): $580 \text{ } \mu\text{g/dL}$ (Normal: $65-380 \text{ } \mu\text{g/dL}$)
$17$-hydroxyprogesterone: $3,800 \text{ ng/dL}$ (Normal: $< 200 \text{ ng/dL}$)
Thyroid-stimulating hormone (TSH): $1.6 \text{ mU/L}$ (Normal: $0.5-5.0 \text{ mU/L}$)
Free thyroxine (T4): $1.1 \text{ ng/dL}$ (Normal: $0.8-2.0 \text{ ng/dL}$)

Transabdominal ultrasonography reveals normal-appearing ovaries with no evidence of cysts.

Which of the following best describes the fundamental pathophysiologic mechanism responsible for this patient's condition?